Gemtesa for Cardiovascular Function in Aging Women

This trial explores whether Gemtesa can improve blood vessel function in aging women by targeting specific receptors (beta3 adrenergic receptors) in their blood vessels. The study involves two main activities: participants place their foot in ice water, and an ultrasound checks blood flow in the arm. The trial seeks healthy women with a body mass index (BMI) below 18 or above 30, who do not have conditions like diabetes or high blood pressure. As an Early Phase 1 trial, this research aims to understand how Gemtesa works in people, offering participants a unique opportunity to contribute to groundbreaking medical research.

The trial information does not specify if you need to stop taking your current medications. However, if you are on anticoagulation therapy or have certain health conditions like cardiovascular disease, you may not be eligible to participate.

Previous studies have shown that Gemtesa (vibegron) is generally safe and well tolerated. For older adults using Gemtesa for overactive bladder (OAB), research found that the rate of high blood pressure matched that of those taking a placebo, which contains no active medicine. Another study showed no significant effect on blood pressure compared to a placebo. Available data indicate no major safety concerns about Gemtesa related to heart health.

Researchers are excited about Gemtesa for improving cardiovascular function in aging women because it offers a novel approach. Unlike current treatments that primarily focus on managing cardiovascular symptoms through lifestyle changes or medications like statins and beta-blockers, Gemtesa is being explored for its potential benefits beyond its known use for bladder issues. This trial is investigating its unique effects on cardiovascular responses, like how blood vessels react to stress and improve blood flow, which could provide new insights and options for women as they age.

Research has shown that Gemtesa, a medication for overactive bladder, might also benefit heart health in older women. Gemtesa relaxes muscles and may enhance energy use while reducing heart-related risks in older adults. Studies have demonstrated that Gemtesa is safe and effective for older adults, with similar outcomes in both older and younger individuals. The medication could potentially widen blood vessels, improving blood flow and heart function. Although primarily used for bladder issues, it might also support heart health. Participants in this trial will undergo either the Cold Pressor Test or Flow Mediated Dilation to assess cardiovascular function.¹²⁶⁷⁸